Patent US5627495A successfully refreshed from Google Patents.
Patent US4668513A successfully refreshed from Google Patents.
US4668513A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for combating snoring
Assignee: Individual
•
Filing: 1985-08-05
•
Granted: 1987-05-26
•
Expires: 2005-08-05
Abstract
Abstract A method for overcoming snoring is disclosed. A composition is used containing a surface active substance, a preserving agent and/or a substance acting bactericidally or fungicidally on the mucous membranes and optionally a substance for softening the mucous membranes in physiological common salt solution as well as optionally further additives which are compatible with the mucous membranes.
Inventors
- 👤 Dietrich Reichert
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 19:41
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0043; A61K31/00; A61K31/13; A61K31/14; A61P; A61P43/00
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
79 words
A method of combating snoring, in normal healthy humans which comprises administering to a snoring victim's nasopharyngeal mucous membranes, shortly prior to sleep a composition containing (a) 0.05 to 2% by weight of a surface active substance compatible with the mucous membranes and (b) 0.01 to 4% by weight of a pharmaceutically acceptable agent selected from the group consisting of a preserving agent and substances acting bactericidally or fungicidally on the mucous membranes, in a physiological common salt solution.
Claim 2
Independent Claim
79 words
A method of combating snoring, in normal healthy humans which comprises administering to a snoring victim's nasopharyngeal mucous membranes, shortly prior to sleep a composition containing (a) 0.05 to 2% by weight of a surface active substance compatible with the mucous membranes and (b) 0.01 to 4% by weight of a pharmaceutically acceptable agent selected from the group consisting of a preserving agent and substances acting bactericidally or fungicidally on the mucous membranes, in a physiological common salt solution.
Claim 3
Dependent Claim
24 words
The method according to claim 1 wherein the surface active agent is selected from the group consisting of anionic and cationic surface active agents.
Claim 4
Dependent Claim
28 words
The method according to claim 2 wherein the anionic and cationic surface active agent is selected from the group consisting of fatty alcohol sulfates, sulfosuccinates and benzalkonium halides.
Claim 5
Dependent Claim
37 words
The method according to claim 3 wherein the preserving agent is a substance selected from the group consisting of ethanol, esters of a p-hydroxybenzoic acid, 2-penoxy-ethanol, benzoic acid and its salts, and sorbic acid and its esters.
Claim 6
Dependent Claim
25 words
The method according to claim 4 wherein the softening compound is at least one substance selected from the group consisting of glycerol, sorbitol and panthenol.
Claim 7
Dependent Claim
29 words
The method according to claim 5 wherein the composition contains additionally at least one substance selected from the group consisting of vitamin A, vitamin E, hydrolases, lipaes and proteases.
Claim 8
Dependent Claim
25 words
The method according to claim 1, wherein the composition further contains 0.1 to 1% by weight of a softening compound for softening the mucous membranes.
Claim 9
Dependent Claim
25 words
The method according to claim 7 wherein the softening compound is at least one substance selected from the group consisting of glycerol, sorbitol and panthenol.
Claim 10
Dependent Claim
36 words
The method according to claim 1 wherein the preserving agent is a substance selected from the group consisting of ethanol, esters of p-hydroxybenzoic acid, 2-phenoxy-ethanol, benzoic acid and its salts, and sorbic acid and its esters.
Claim 11
Dependent Claim
34 words
The method according to claim 1 wherein as substance (a) and agent (b) one compound is selected in an amount of 0.01 to 4.0% by weight which exhibits both surface activity and preservative effect.
Claim 12
Dependent Claim
20 words
The method according to claim 10 wherein the compound is contained in an amount of 0.05 to 2% by weight.
Claim 13
Dependent Claim
15 words
The method according to claim 11, wherein the composition contains benzalkonium chloride as said compound.
Claim 14
Dependent Claim
14 words
The method according to claim 1 wherein the composition contains chlorobutanol as said substance.
Claim 15
Dependent Claim
29 words
The method according to claim 1 wherein the composition contains additionally at least one substance selected from the group consisting of vitamin A, vitamin E, hydrolases, lipases and proteases.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-05-25 | 1990-11-24 | 1991-05-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-05-25 | 1994-11-24 | 1995-05-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-05-25 | 1998-11-24 | 1999-05-26 | $7700.00 | Window Closed / Lapsed |